SCHEMBL20201279

SCHEMBL20201279

c1ccc(N(c2ccc3c(c2)sc2ccccc23)c2ccc3c(c2)sc2ccc(N(c4ccc5ccccc5c4)c4ccc5ccccc5c4)cc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
ALDH1A1 P00352 4/20 0.41
RAB9A P51151 2/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GPR3 P46089 1/20 0.39
PTPN7 P35236 1/20 0.36
DUSP3 P51452 1/20 0.36
PTPN12 Q05209 1/20 0.36
PTPN22 Q9Y2R2 1/20 0.36
CYP1A2 P05177 2/20 0.35
L3MBTL1 Q9Y468 4/20 0.33
TDP1 Q9NUW8 3/20 0.33
POLB P06746 1/20 0.33
PTGIR P43119 1/20 0.33
KDM4E B2RXH2 4/20 0.32
NPC1 O15118 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19429064 1.00 MAPT (0.41) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL21968669 1.00 MAPT (0.41) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL19429057 1.00 MAPT (0.41) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL24154575 0.97 MAPT (0.42) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL18927735 0.97 MAPT (0.36) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL21966652 0.97 MAPT (0.36) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL19429033 0.97 MAPT (0.36) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL23515783 0.97 MAPT (0.36) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL24154587 0.96 MAPT (0.41) MAPTALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL28522152 0.96 GPR3 (0.42) MAPTALDH1A1RAB9AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210098706-A1 ORGANIC ELECTRIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRIC ELEMENT AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2021-04-01 US disclosed
US-10651391-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2020-05-12 US disclosed
US-20190245148-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-08-08 US disclosed
US-10319915-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2019-06-11 US disclosed
US-20180151806-A2 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-31 US disclosed
US-20180151806-A2 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210098706-A1 ORGANIC ELECTRIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRIC ELEMENT AND ELECTRONIC DEVICE THEREOF EED, PIEZO1, TRPA1 MAPT 655/4885ALDH1A1 1943/4885RAB9A 2263/4885
US-10319915-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof EML4, EBPL, NFE2L2 MAPT 881/4885ALDH1A1 1021/4885RAB9A 3481/4885
US-20190245148-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EML4, EBPL, NFE2L2 MAPT 881/4885ALDH1A1 1021/4885RAB9A 3481/4885
US-20180151806-A2 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EBPL, EML4, NFE2L2 MAPT 975/4885ALDH1A1 919/4885RAB9A 3711/4885
US-10651391-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof EML4, EBPL, NFE2L2 MAPT 881/4885ALDH1A1 1021/4885RAB9A 3481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.